Hani Naseef
Impact in
- Pharmaceutical Science top 10%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
-
- Antibiotic Use and Resistance 6
-
- Pharmaceutical Practices and Patient Outcomes 6
- Co-authors
- M. EfentakisMarilena VlachouNi’meh Al-ShamiP. A. TarantiliA. G. AndreopoulosFuad Al‐RimawiDonia KaramanSabino Aurelio Bufo
- Journals
- Patient Preference and Adherence (5 papers)Infection and Drug Resistance (2 papers)Saudi Pharmaceutical Journal (2 papers)Journal of Biomaterials Applications (2 papers)Pharmaceutics (2 papers)
- Partner nations
- Palestinian TerritoryGreeceUnited States
In The Last Decade
Hani Naseef
42 papers receiving 285 citations
Peers
Comparison fields: 5 of 114
- Pharmaceutical Science 54
- Applied Microbiology and Biotechnology 14
- Analytical Chemistry 43
- Geriatrics and Gerontology 15
- Molecular Medicine 16
Countries citing papers authored by Hani Naseef
This map shows the geographic impact of Hani Naseef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hani Naseef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hani Naseef more than expected).
Fields of papers citing papers by Hani Naseef
This network shows the impact of papers produced by Hani Naseef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hani Naseef. The network helps show where Hani Naseef may publish in the future.
Co-authorship network
The 22 scholars most cited alongside Hani Naseef, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 6 | |
| 7 | 2023 | 16 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 5 | |
| 15 | 2022 | 1 | |
| 16 | 2022 | 3 | |
| 17 | 2022 | 1 | |
| 18 | 2022 | 7 | |
| 19 | 2022 | 2 | |
| 20 | 2010 | 18 |
About Hani Naseef
Hani Naseef is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology, Pharmaceutical Science, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 47 papers that have together received 298 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (6 papers), Antibiotic Use and Resistance (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Drug Solubulity and Delivery Systems (5 papers), COVID-19 Clinical Research Studies (5 papers), COVID-19 and Mental Health (4 papers), Analytical Methods in Pharmaceuticals (4 papers) and Advanced Drug Delivery Systems (4 papers). The work is most often cited by research in Pharmaceutical Science (54 citations), Applied Microbiology and Biotechnology (14 citations), Analytical Chemistry (43 citations), Geriatrics and Gerontology (15 citations) and Molecular Medicine (16 citations). Hani Naseef has collaborated with scholars based in Palestinian Territory, Greece and United States. Frequent co-authors include M. Efentakis, Marilena Vlachou, Ni’meh Al-Shami, P. A. Tarantili, A. G. Andreopoulos, Fuad Al‐Rimawi, Donia Karaman, Sabino Aurelio Bufo, Laura Scrano and Amin Mahmood Thawabteh. Their work appears in journals such as Patient Preference and Adherence, Infection and Drug Resistance, Saudi Pharmaceutical Journal, Journal of Biomaterials Applications and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.